Crossmark

Axial Spondyloarthritis and Diagnostic Challenges: Over-diagnosis, Misdiagnosis, and Under-diagnosis

Published Online: 2023-01-05

Published Print: 2023-03

Authors

Bittar, Mohamad https://orcid.org/0000-0001-9283-7462
Khan, Muhammad Asim

Magrey, Marina
License Information

Text and Data Mining valid from 2023-01-05

Version of Record valid from 2023-01-05
More Information

Article History

Accepted: 21 December 2022

First Online: 5 January 2023

Declarations

:

: Mohamad Bittar: None.Muhammad Asim Khan: None.Marina Magrey: Consultant for Abbvie, UCB Pharma, Novartis, Janssen, Eli Lilly, Pfizer and Bristol Myers Squibb (BMS). Research with BMS; Amgen and Celgene Corporation.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

Document is current